Baypointe Rehab Center | |
50 Christy Place, Brockton, Massachusetts 02301 | |
(508) 580-6800 | |
Name | Baypointe Rehab Center |
---|---|
Location | 50 Christy Place, Brockton, Massachusetts |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 169 |
Occupancy Rate | 75.03% |
Medicare ID (CCN) | 225690 |
Legal Business Name | Baypointe Rehab Center Llc |
Ownership Type | For Profit - Partnership |
NPI Number | 1114905486 |
Organization Name | BAYPOINTE NURSING HOME INC |
Doing Business As | BAYPOINTE REHAB & SKILLED CARE CENTER |
Address | 50 Christy Pl, Brockton, MA 02301 |
Phone Number | 508-580-6800 |
News Archive
People with schizophrenia have an alteration in a pattern of brain electrical activity associated with learning and memory. Now, researchers from the National Institutes of Health and Sweden's Karolinska Institute have identified in mouse brain tissue a molecular switch that, when thrown, increases the strength of this electrical pattern. The researchers found that adding the brain chemical Neuregulin-1 to the brain tissue boosted the electrical signals that the tissue generated.
When Pamela DeSalvo read the clinical note from her doctor's visit, the words on the page hit her hard: "clinically morbidly obese." She knew she was overweight, but seeing those three words together shocked her. It also inspired her to start losing weight.
For decades, immunologists have been trying to train the transplant recipient's immune system to accept transplanted cells and organs without the long-term use of anti-rejection drugs. New University of Minnesota preclinical research shows that this is now possible.
Accuray Incorporated announced today that the first CyberKnife M6 and TomoTherapy Systems in Chile are now installed at Fundacion Arturo Lopez Perez (FALP) Cancer Institute in Santiago, Chile. FALP is also the first hospital in Latin America to install both Accuray systems.
Temporal lobe epilepsy, the most common form of epilepsy, is characterized by recurrent seizures throughout life and often behavioral abnormalities, with devastating impacts on patients and their families. Unfortunately, the condition is often not responsive to anticonvulsants. Now scientists report online June 20 in the Cell Press journal Neuron that targeting a particular signaling pathway in mice can prevent the development of temporal lobe epilepsy with just two weeks of treatment, offering hope that researchers will be able to develop effective drugs to mitigate recurrent seizures and the development of epilepsy.
› Verified 6 days ago
NPI Number | 1467485235 |
Organization Name | BAYPOINTE NURSING HOME INC |
Doing Business As | BAYPOINTE REHABILITATION & SKILLED CARE CENTER |
Address | 50 Christy Place, Brockton, MA 02301 |
Phone Number | 508-580-6800 |
News Archive
People with schizophrenia have an alteration in a pattern of brain electrical activity associated with learning and memory. Now, researchers from the National Institutes of Health and Sweden's Karolinska Institute have identified in mouse brain tissue a molecular switch that, when thrown, increases the strength of this electrical pattern. The researchers found that adding the brain chemical Neuregulin-1 to the brain tissue boosted the electrical signals that the tissue generated.
When Pamela DeSalvo read the clinical note from her doctor's visit, the words on the page hit her hard: "clinically morbidly obese." She knew she was overweight, but seeing those three words together shocked her. It also inspired her to start losing weight.
For decades, immunologists have been trying to train the transplant recipient's immune system to accept transplanted cells and organs without the long-term use of anti-rejection drugs. New University of Minnesota preclinical research shows that this is now possible.
Accuray Incorporated announced today that the first CyberKnife M6 and TomoTherapy Systems in Chile are now installed at Fundacion Arturo Lopez Perez (FALP) Cancer Institute in Santiago, Chile. FALP is also the first hospital in Latin America to install both Accuray systems.
Temporal lobe epilepsy, the most common form of epilepsy, is characterized by recurrent seizures throughout life and often behavioral abnormalities, with devastating impacts on patients and their families. Unfortunately, the condition is often not responsive to anticonvulsants. Now scientists report online June 20 in the Cell Press journal Neuron that targeting a particular signaling pathway in mice can prevent the development of temporal lobe epilepsy with just two weeks of treatment, offering hope that researchers will be able to develop effective drugs to mitigate recurrent seizures and the development of epilepsy.
› Verified 6 days ago
NPI Number | 1598214967 |
Organization Name | BAYPOINTE REHAB CENTER, LLC |
Address | 50 Christy Pl, Brockton, MA 02301 |
Phone Number | 508-580-6800 |
News Archive
People with schizophrenia have an alteration in a pattern of brain electrical activity associated with learning and memory. Now, researchers from the National Institutes of Health and Sweden's Karolinska Institute have identified in mouse brain tissue a molecular switch that, when thrown, increases the strength of this electrical pattern. The researchers found that adding the brain chemical Neuregulin-1 to the brain tissue boosted the electrical signals that the tissue generated.
When Pamela DeSalvo read the clinical note from her doctor's visit, the words on the page hit her hard: "clinically morbidly obese." She knew she was overweight, but seeing those three words together shocked her. It also inspired her to start losing weight.
For decades, immunologists have been trying to train the transplant recipient's immune system to accept transplanted cells and organs without the long-term use of anti-rejection drugs. New University of Minnesota preclinical research shows that this is now possible.
Accuray Incorporated announced today that the first CyberKnife M6 and TomoTherapy Systems in Chile are now installed at Fundacion Arturo Lopez Perez (FALP) Cancer Institute in Santiago, Chile. FALP is also the first hospital in Latin America to install both Accuray systems.
Temporal lobe epilepsy, the most common form of epilepsy, is characterized by recurrent seizures throughout life and often behavioral abnormalities, with devastating impacts on patients and their families. Unfortunately, the condition is often not responsive to anticonvulsants. Now scientists report online June 20 in the Cell Press journal Neuron that targeting a particular signaling pathway in mice can prevent the development of temporal lobe epilepsy with just two weeks of treatment, offering hope that researchers will be able to develop effective drugs to mitigate recurrent seizures and the development of epilepsy.
› Verified 6 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
People with schizophrenia have an alteration in a pattern of brain electrical activity associated with learning and memory. Now, researchers from the National Institutes of Health and Sweden's Karolinska Institute have identified in mouse brain tissue a molecular switch that, when thrown, increases the strength of this electrical pattern. The researchers found that adding the brain chemical Neuregulin-1 to the brain tissue boosted the electrical signals that the tissue generated.
When Pamela DeSalvo read the clinical note from her doctor's visit, the words on the page hit her hard: "clinically morbidly obese." She knew she was overweight, but seeing those three words together shocked her. It also inspired her to start losing weight.
For decades, immunologists have been trying to train the transplant recipient's immune system to accept transplanted cells and organs without the long-term use of anti-rejection drugs. New University of Minnesota preclinical research shows that this is now possible.
Accuray Incorporated announced today that the first CyberKnife M6 and TomoTherapy Systems in Chile are now installed at Fundacion Arturo Lopez Perez (FALP) Cancer Institute in Santiago, Chile. FALP is also the first hospital in Latin America to install both Accuray systems.
Temporal lobe epilepsy, the most common form of epilepsy, is characterized by recurrent seizures throughout life and often behavioral abnormalities, with devastating impacts on patients and their families. Unfortunately, the condition is often not responsive to anticonvulsants. Now scientists report online June 20 in the Cell Press journal Neuron that targeting a particular signaling pathway in mice can prevent the development of temporal lobe epilepsy with just two weeks of treatment, offering hope that researchers will be able to develop effective drugs to mitigate recurrent seizures and the development of epilepsy.
› Verified 6 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 1 |
Total Amount of Fines in Dollars | $650 |
Number of Payment Denials | 0 |
Total Number of Penalties | 1 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 18.21 | 14.46 |
Percentage of long-stay residents who lose too much weight | 3.55 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 69.47 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 2.42 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 3.33 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 1.38 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 2 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 99.11 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 12.02 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 99.79 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 2.18 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 17.95 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 15.91 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 5.99 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 97.23 | 95.98 |
Percentage of short-stay residents who made improvements in function | 59.02 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 98.65 | 82.93 |
News Archive
People with schizophrenia have an alteration in a pattern of brain electrical activity associated with learning and memory. Now, researchers from the National Institutes of Health and Sweden's Karolinska Institute have identified in mouse brain tissue a molecular switch that, when thrown, increases the strength of this electrical pattern. The researchers found that adding the brain chemical Neuregulin-1 to the brain tissue boosted the electrical signals that the tissue generated.
When Pamela DeSalvo read the clinical note from her doctor's visit, the words on the page hit her hard: "clinically morbidly obese." She knew she was overweight, but seeing those three words together shocked her. It also inspired her to start losing weight.
For decades, immunologists have been trying to train the transplant recipient's immune system to accept transplanted cells and organs without the long-term use of anti-rejection drugs. New University of Minnesota preclinical research shows that this is now possible.
Accuray Incorporated announced today that the first CyberKnife M6 and TomoTherapy Systems in Chile are now installed at Fundacion Arturo Lopez Perez (FALP) Cancer Institute in Santiago, Chile. FALP is also the first hospital in Latin America to install both Accuray systems.
Temporal lobe epilepsy, the most common form of epilepsy, is characterized by recurrent seizures throughout life and often behavioral abnormalities, with devastating impacts on patients and their families. Unfortunately, the condition is often not responsive to anticonvulsants. Now scientists report online June 20 in the Cell Press journal Neuron that targeting a particular signaling pathway in mice can prevent the development of temporal lobe epilepsy with just two weeks of treatment, offering hope that researchers will be able to develop effective drugs to mitigate recurrent seizures and the development of epilepsy.
› Verified 6 days ago
Brockton Health Center Location: 2 Beaumont Avenue, Brockton, Massachusetts 02302 Phone: (508) 588-8550 | |
Alliance Health At West Acres Location: 804 Pleasant Street, Brockton, Massachusetts 02301 Phone: (508) 583-6000 | |
Guardian Center (the) Location: 888 North Main Street, Brockton, Massachusetts 02301 Phone: (508) 587-6556 | |
St Joseph Manor Health Care Inc Location: 215 Thatcher Street, Brockton, Massachusetts 02302 Phone: (508) 583-5834 | |
Baypointe Rehab Center Location: 50 Christy Place, Brockton, Massachusetts 02301 Phone: (508) 580-6800 |